NASDAQ:CTMX

Cytomx Therapeutics Stock Predictions

etoro logo Buy CTMX
*Your capital is at risk
$3.16
-0.290 (-8.41%)
At Close: Jun 02, 2026
Currently predicting for Thu, 4 Jun 2026

CTMX Prediction Chart

CTMX Predictions History

Latest community submissions for CTMX.
Predictor Target Session Target Price Result Direction Accuracy Score
Dec 1, 2025 $4.39 +2.57% $4.29 V 97.67% 1
Dec 1, 2025 Bullish $4.29 V 1
Nov 28, 2025 $4.10 -2.95% $4.28 X 95.69% 0
Nov 28, 2025 $4.14 -1.84% $4.28 X 96.78% 0
Nov 28, 2025 Bullish $4.28 V 1
Nov 25, 2025 $3.84 -3.30% $4.15 X 92.51% 0
Nov 25, 2025 $3.89 -2.06% $4.15 X 93.69% 0
Nov 25, 2025 Bullish $4.15 V 1
Nov 19, 2025 Bullish $3.63 X 0
Nov 18, 2025 $3.69 +4.02% $3.66 V 99.10% 3
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CTMX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT CYTOMX THERAPEUTICS
CytomX Therapeutics
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical trials for the treatment of breast cancer; CX-2029 that is in Phase II clinical trials for the treatme...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE